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Abstract
Background
Plasmalogens are either phosphatidylcholine (PC P) or phosphatidylethanolamine (PE P)
glycerophospholipids containing a vinyl ether moiety in sn-1-position and an esterified fatty
acid in sn-2 position. Multiple functions have been proposed, including reservoir of precur-
sors for inflammatory mediators, modulation of membrane fluidity, and anti-oxidative proper-
ties. They could therefore play a role under conditions of metabolic stress. Especially
enzymatically modified LDL (eLDL) and oxidatively modified LDL (oxLDL) represent modifi-
cations of LDL that are taken up by macrophages in atherosclerotic plaques. The aim of this
study was to analyze plasmalogen related effects of eLDL and oxLDL in human monocyte
derived macrophages, as well as the effects of HDL3 mediated deloading.
Methods
Elutriated monocytes from nine healthy donors were differentiated in vitro for four days.
Macrophages were then loaded with native LDL, eLDL and oxLDL for 24h and subsequently
deloaded with HDL3 for another 24h. Lipidomic and transcriptomic profiles were obtained.
Results
Loading of macrophages with eLDL and oxLDL led to a transient but strong elevation of lyso-
phosphatidylcholine (LPC) most likely through direct uptake. Only eLDL induced increased
levels of total PC, presumably through an induction of PC synthesis. On the other hand treat-
ment with oxLDL led to a significant increase in PC P. Analysis of individual lipid species
showed lipoprotein and saturation specific effects for LPC, PC P and PE P species. Mem-
brane fluidity was decreased by the large amount of FC contained in the lipoproteins, as indi-
cated by a lower PC to FC ratio after lipoprotein loading. In contrast the observed changes in
the saturated to mono-unsaturated fatty acid (SFA to MUFA) and saturated to poly-unsatu-
rated fatty acid (SFA to PUFA) ratios in PE P could represent a cellular reaction to counteract
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this effect by producing more fluid membranes. Transcriptomic analysis showed considerable
differences between eLDL and oxLDL treated macrophages. As a common feature of both
lipoproteins we detected a strong downregulation of pathways for endogenous lipid synthesis
as well as for exogenous lipid uptake. Deloading with HDL3 had only minor effects on total lipid
class as well as on individual lipid species levels, most of the time not reaching significance.
Interestingly treatment with HDL3 had no effect on membrane fluidity under these conditions,
although incubation with HDL3 was partially able to counteract the oxLDL induced transcrip-
tomic effects. To investigate the functional effect of lipoprotein treatment on macrophage
polarization we performed surface marker flow cytometry. Under our experimental conditions
oxLDL was able to partially shift the surface marker pattern towards a pro-inflammatory M1-
like phenotype. This is consistent with the consumption of arachidonic acid containing PE P
species in oxLDL treated cells, presumably for the synthesis of inflammatory mediators.
Summary
Our findings provide novel data on the lipoprotein induced, lipidomic and transcriptomic
changes in macrophages. This can help us better understand the development of metabolic,
inflammatory diseases as well as improve our background knowledge on lipid biomarkers in
serum.
Introduction
The coordinated function of the human immune system is inextricably linked to lipid metabo-
lism. Besides their role as exogenous signaling molecules, lipids also control complex endoge-
nous cellular processes such as phagocytic differentiation [1]. Macrophages as the major
phagocytic cell type play a central role in innate immunity. They are of great importance for the
pathogenesis of atherosclerosis and insulin resistance in metabolic syndrome patients [2]. Fatty
streaks in the aorta and other arterial blood vessels consist to a large extent of macrophage
derived foam cells that contain large amounts of cholesterol either in lipid droplets or endolyso-
somes (phospholipidosis) [3, 4]. These lipid loaded cells play a key role in the persistence of
local, low grade inflammation [5]. Macrophage phenotypes are classically characterized as a
continuum between two extremes: the pro-inflammatory M1 phenotype with high levels of IL-
12 and the anti-inflammatory M2 phenotype secreting cytokines such as IL-10 [6]. This polari-
zation also affects macrophage surface marker expression and chemokine secretion [6].
Cholesterol in atherosclerotic lesions accumulates mainly from low density lipoprotein
(LDL) particles that represent the major cholesterol transport vehicle in human plasma. Under
disease conditions, LDL particles are degraded locally by hydrolytic enzymes. This enzymati-
cally modified LDL (eLDL) is taken up with a higher efficiency by macrophages [7]. It is recog-
nized and internalized into macrophages by type I and type II phagocytosis. This process is
mediated by opsonin receptors for complement (CD11b/CD18, CD11c/CD18), pentraxin-
and IgG-binding Fcγ-receptors I-III (CD64, CD32, CD16), and the IgM (Fcμ/IgM receptor)
[8–10]. The resulting excess uptake ultimately leads to the formation of foam cells.
Furthermore reaction of LDL particles with free radicals and peroxidases leads to the for-
mation of oxidatively modified LDL (oxLDL). oxLDL is more reactive than native LDL or
eLDL and leads to tissue damage and attraction of additional pro-inflammatory cells [11, 12].
In contrast to eLDL, it is preferentially taken up through charge and motif dependent
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scavenger receptors (e.g. CD36 or LOX1R) and damage-associated molecular pattern molecule
(DAMP)-receptor complexes [10]. Clinically plasma levels of oxLDL show a correlation with
cardiovascular disease while the administration of antioxidants has been shown to exhibit a
protective effect against atherosclerosis [13]. Loading of macrophages with oxLDL induces
endolysosomal phospholipidosis [10]. oxLDL as well as eLDL, have been identified in vivo in
human atherosclerotic vessel walls using specific antibodies [4, 14].
Plasmalogens are a class of mostly phosphatidylcholine (PC P) or phosphatidylethanol-
amine (PE P) containing phospholipids that encompass a vinyl ether moiety in the sn-1-posi-
tion of the glycerol backbone and an ester bond in sn-2. They are found in all mammalian
cells, comprising about 18% of all phospholipids [15] and 65% of all phosphatidylethanolamine
(PE) phospholipids. They are particularly abundant in neurons, cardiac and skeletal muscle,
but also occur in sizable amounts in platelets, neutrophils and macrophages [16]. Although
plasmalogens have been first described 80 years ago, their physiological purpose even now
remains partially enigmatic. Over the years a range of functions has been proposed, that are
mostly attributable to the characteristic ether-bond: (1) storage of precursor fatty acids in sn-2
position for the synthesis of n-3 and n-6 prostanoids as inflammatory mediators, (2) modula-
tion of membrane fluidity and regulation of endo- and exocytosis, and (3) anti-oxidative (scav-
enger) properties that protect the cell under conditions of oxidative stress [17].
Until recently, atherosclerosis research has focused primarily on abundant plasma lipids
such as cholesterol and triglycerides. Plasmalogens and especially cellular plasmalogen species
have been studied to a considerably lesser extent. Data from hypertensive patients show an
ether-lipid deficiency in their plasma [18]. Therefore in the current study we focused on plas-
malogens in human primary macrophages following treatment with eLDL and oxLDL. Fur-
thermore there is evidence that ether lipids are able to modulate transcriptional networks. To
this end we additionally performed microarray analysis to study effects on gene expression.
Materials and methods
Materials
If not otherwise stated all materials were obtained from Sigma (Munich, Germany). Carrier-
free macrophage colony-stimulating factor (M-CSF) was obtained from R&D (Wiesbaden,
Germany). HPLC grade methanol and chloroform were from Merck (Darmstadt, Germany),
plasmalogen standards from Avanti Polar Lipids (Alabaster, AL, USA).
Isolation of low density lipoprotein (LDL) and high density lipoprotein
subfraction 3 (HDL3)
Lipoproteins were isolated from fresh, non-lipemic human plasma of healthy donors by a
modified sequential preparative ultracentrifugation in KBr gradients (HDL3 d = 1.125–1.21 g/
ml and native LDL d = 1.019–1.063 g/mL) followed by extensive dialysis and filter sterilization
according to published methods [19]. All lipoprotein concentrations mentioned are protein
concentrations determined by the Lowry method. Lipoprotein fractions were stored in the
presence of 0.5 mmol/l EDTA at 4˚C. None of the blood donors had diabetes mellitus or
underwent treatment for arterial hypertension.
Preparation of enzymatically modified and oxidized LDL
eLDL was generated under sterile conditions. To this end native LDL was diluted to 2 mg/ml
protein in PBS (w/o Ca++, Mg++) and 6.6 μg/ml trypsin (Sigma, Germany) as well as 400 μg/ml
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cholesterylester hydrolase (Seikagaku, Japan) were added. Subsequently the solution was incu-
bated at 37˚C for 48 h.
Oxidized LDL was attained by dialyzing purified LDL fractions (1 mg protein/ml) against
5 μM CuSO4 for 40 h. The oxidation process was stopped by repeated and extensive dialysis in
PBS/EDTA. Afterwards, the oxLDL was sterile filtered and the protein content was determined
by the Lowry method. The degree of oxidation was controlled by electrophoresis.
Blood cell isolation, in vitro differentiation and lipid loading of human
monocytes
Blood samples were obtained from nine healthy normo-lipidemic volunteers recruited from
blood donors with apoE3/E3 phenotype. Informed consent and approval of the Hospital Ethics
Committee were obtained (Universita¨tsklinikum Regensburg, Ethikkommission der medizi-
nischen Fakulta¨t, proposal 08/119). Donors were fully informed of the possible complications
and gave their written consent for the procedure. Blood cells were collected by leukapheresis
in a Spectra cell separator (Gambro BCT, CO, USA), followed by counterflow centrifugation
elutriation as described elsewhere [20]. In brief, cells were elutriated in the following order:
platelets, lymphocytes, monocytes and then granulocytes. Aliquots of the different cell frac-
tions were analyzed for cell purity on a BD FACSCanto II flow cytometer (Becton Dickinson,
Heidelberg, Germany) using BD FACSDiva Software. Cell numbers were determined on an
ADVIA 120 automated cell counter (Siemens Healthcare Diagnostics GmbH, Bad Nauheim,
Germany). Phagocytic differentiation of monocytes to macrophages was conducted by cultur-
ing monocytes in macrophage serum-free medium (Invitrogen, Germany) at 106 cells/ml in
tissue culture plates (6-well flat bottom; Sarstaedt, Germany) in an incubator (5% CO2, 37˚C)
with the addition of recombinant human monocyte-colony stimulating factor (rhM-CSF, 50
ng/ml, R&D Systems, USA).
Loading and deloading with lipoproteins
After four days of differentiation, macrophages were loaded with LDL preparations for 24
hours followed by harvesting. eLDL was used at 40 μg/ml and copper oxidized LDL (oxLDL)
at 80 μg/ml. Deloading of control, eLDL or oxLDL loaded cells was carried out with HDL3 at a
concentration of 100 μg/mL for further 24 hours. After washing with PBS, the cell pellets were
stored at −80˚C. Protein concentrations were measured according to Smith et al. [21] using
the bicinchoninic acid assay (BCA) Assay from Uptima-Interchim (Montluc¸on, France) with
serial dilutions of bovine serum albumin as standards.
Flow cytometry
Flow cytometric analysis of surface marker expression was performed on a FACS Canto II
flow cytometer (Becton Dickinson) using a five-color setup. Anti CD206 FITC, Anti CD163
PE and Anti CD14 PerCP were bought from Becton-Dickinson. Anti-CCR7 APC was supplied
by R&D systems and Anti CD11c PC7 by IOT/Beckman-Coulter.
Lipid mass spectrometry
Cell pellets were dissolved in 0.2% SDS solution and disrupted by sonication on ice (Soniprep
150, Beun de Ronde, Abcoude, Netherlands). An aliquot corresponding to 100 μg was used for
mass spectrometric lipid analysis. Lipid extraction was performed according to the method of
Bligh and Dyer [22] in the presence of not naturally occurring lipid species as internal stan-
dards. The chloroform phase was dried in a vacuum centrifuge (SpeedVac, ThermoFisher
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Scientific) and dissolved in 10 mM ammonium acetate in methanol/chloroform (3:1 vol/vol).
Samples were analyzed by ESI-MS/MS in positive ion mode after direct flow injection using
the analytical setup and data analysis algorithms described previously [23]. A precursor ion
scan of m/z 184 specific for phosphocholine containing lipids was used for phosphatidylcho-
line (PC) and lysophosphatidylcholine (LPC) [23, 24]. PE-plasmalogens were quantified
according to the principles described by Zemski, Berry, and Murphy [25]. For this purpose
fragment ions of m/z 364, 390 and 392 were used for PE P-16:0, PE P-18:1 and PE P-18:0 spe-
cies, respectively. After identification of relevant lipid species, selected ion monitoring analysis
was performed. Free cholesterol was quantified according to the methodology of Liebisch et al.
[26]. Glycerophospholipid annotation is generally based on the assumption of even numbered
carbon chains only.
Gene expression analysis
Cells were harvested, washed in PBS, resuspended in buffer RLT and RNA was isolated using
the RNeasy Mini Kit (Qiagen) according to the manufacturer´s instructions. Purity and integ-
rity of the RNA were determined on the Agilent 2100 Bioanalyzer with the RNA 6000 Nano
LabChip reagent set (Agilent Technologies). RNA was quantified using the Nanodrop ND-
1000—UV/Vis Spectrophotometer (PeqLab).
For gene array analysis we used a modified standard Agilent 4x44K microarray (014850)
containing 205 free positions (Agilent Technologies). 201 probes were added to these positions,
corresponding to 119 genes previously not represented on the array. 300 ng of total RNA were
labeled with Cy3 using the Agilent Quick-Amp Labeling Kit—1 color according to the manu-
facturer´s instructions. cRNA was purified with the RNeasy Mini Kit (Qiagen). cRNA amounts
and labeling efficiency were determined on a NanoDrop ND-1000 photometer (PeqLab). The
Agilent Gene Expression Hybridization Kit was used for hybridization. Arrays were incubated
for 17 hours at 65˚C in Agilent SureHyb chambers in a hybridization oven while rotating. Wash
steps were performed according to the manufacturer’s instructions. Scanning was done with the
Agilent G2565CA Microarray Scanner System. The resulting TIFF files were processed with
Agilent Feature Extraction software (10.7). Microarray data are available in the ArrayExpress
database (www.ebi.ac.uk/arrayexpress) under accession number E-MTAB-2298.
Statistical analysis
All data was analyzed in SPSS 20 (IBM). Means were compared by one-way ANOVA followed
by post-hoc testing with LSD correction. P-values of less than 0.05 were regarded as statistically
significant.
The hypergeometrical score for transcriptional regulation was calculated as previously
described according to the method of Kondrakhin et al. [27]. Significantly regulated tran-
scripts (hypergeometrical score >6) were subjected to the PANTHERdb overrepresentation
test (Fisher’s exact test with FDR multiple test correction, release 20170413) and annotated
with Reactome pathways [28].
Results
Total phospholipids
Lipid extracts from macrophage cell pellets were analyzed for their phospholipid content after
four days of phagocytic differentiation and one additional day of loading with eLDL and
oxLDL. As shown in Fig 1A there was no significant effect on total PE, PE P and phosphatidyl-
serine (PS) levels. Loading with oxLDL led to significant increases in PC P and lyso-
Plasmalogens in human, lipid loaded macrophages
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Fig 1. Analysis of total phospholipid levels. (A) Loading of macrophages with modified lipoproteins leads to significant increases
in total PC, PC P and LPC species on day 5. (B) Subsequent deloading with HDL3 for 24 hours does not have a significant effect
compared to loaded control cells. n = 9 for all experiments except n = 8 for 6d MCSF control data, means +/- 1 standard deviation
(SD), ( p<0.05,  p<0.01,  p<0.001).
https://doi.org/10.1371/journal.pone.0205706.g001
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phosphatidylcholine (LPC) species. The observable increase in total PC levels did not reach
statistical significance. Loading with eLDL significantly increased total PC and LPC levels.
To assess the effect of HDL-mediated deloading, cells were incubated for another 24 hours
with purified HDL3. As shown in Fig 1B, on day six the lipoprotein induced elevations in PC
and LPC species were smaller than on day five and partially lost their statistical significance.
Particularly levels of LPC species were almost back to control levels. However the significant
effect of oxLDL treatment on total PC P persisted also on day six. Treatment with HDL3 lead
to small reductions of total PC, PC P and LPC in oxLDL loaded cells, but none of these changes
was able to reach statistical significance.
Individual LPC and PC plasmalogen species
Loading with either eLDL or oxLDL resulted in a comparable rise in total LPC on day five (Fig
1). However analysis of individual LPC species exhibited a lipoprotein dependent species pat-
tern (Fig 2A). eLDL primarily raised levels of the unsaturated LPC species 18:1, 18:2 and 20:4.
Unfortunately the exact positions of the double bonds could not be inferred from the mass-
spectrometric data. Loading with oxLDL on the other hand strongly elevated the saturated
LPC species 16:0 and 18:0.
The oxLDL induced increase in total PC P was significant on day five as well as on day six.
Therefore the detailed lipid species analysis was performed using measurements from day six.
As shown in Fig 2B, especially saturated, mono-unsaturated and di-unsaturated PC P species
were prominently higher in oxLDL treated cells compared to untreated controls. Treatment
with eLDL lowered PC P-30:0 levels and increased PC P-34:2 and PC P-36:4 levels signifi-
cantly. In comparison changes induced by eLDL were smaller than those induced by oxLDL.
Individual PE plasmalogen species
Lipoproteins contain a variety of PE P species that can be modified by oxidative and enzymatic
treatment [29]. Nevertheless as previously shown total PE P levels in macrophages did not
change significantly after lipoprotein loading (Fig 1). Instead saturation specific changes could
be observed at the level of individual species (Fig 3A and 3B). In eLDL treated cells, all PE P
species containing saturated, mono-unsaturated and three-times unsaturated acyl-residues in
sn-2 position were lower than in control cells (Fig 3A). PE plasmalogens with 22:6 in sn-2 were
increased by eLDL loading. In contrast treatment with oxLDL led to a different and partially
diametrical pattern. While sn-2 saturated species were also reduced, albeit to a lower extent,
monounsaturated species showed an increase and 22:6 containing PE P species were slightly
decreased. Changes induced by loading with oxLDL were in general less pronounced.
Alterations of PE P concentrations induced by HDL3 mediated deloading were also consid-
erably smaller than load effects (Fig 3B). Interestingly they also exhibited a saturation depen-
dency with partly opposing effects depending on the loading lipoprotein. Cells that were
previously loaded with eLDL showed increases in 16:0, 16:1 and 20:5 containing species. HDL3
deloading after oxLDL loading in contrast led to decreases in 18:0, 16:1, 18:1, 18:2 containing
species, as well as to increases in 16:0 and 20:5 containing PE Ps.
Arachidonic acid (AA, 20:4) containing plasmalogens represent the lion’s share of all PE P
species and account for around 50% of all cellular PE Ps. As shown in Fig 3C and 3D, loading
with eLDL does not significantly influence the mean percentage of AA containing PE Ps.
oxLDL on the other hand induced a small, but not statistically significant lowering of AA con-
taining plasmalogens 24h after lipid loading that became more pronounced and statistically
significant after 48h (Fig 3D, p = 0.011 compared to MSCF control cells). 24h of deloading
Plasmalogens in human, lipid loaded macrophages
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Fig 2. Individual LPC and PC P species after lipid loading. (A) Individual LPC species on day five show saturation and lipoprotein dependent concentration changes
(B) Modulation of PC P species after lipoprotein loading and subsequent 24h of HDL3 mediated deloading on experimental day six. For individual PC P only species
with detectable levels are shown. n = 9 for all experiments except n = 8 for 6d MCSF control data., means +/- SD. ( p<0.05,  p<0.01,  p<0.001).
https://doi.org/10.1371/journal.pone.0205706.g002
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with HDL3 was not able to restore significantly higher levels of AA containing PE Ps (p = 0.35
compared to oxLDL loaded cells).
Analysis of membrane fluidity
Cellular phospholipid content represents an important factor determining membrane fluidity.
Especially the ratios of saturated (SFA) to mono- (MUFA) and poly- unsaturated (PUFA) acyl
residue containing lipids as well as the ratio of total PC to free cholesterol ((PC+PC P)/FC) are
generally regarded as indicators of membrane fluidity in cellular systems.
As shown in Fig 4A, loading with eLDL did not lead to changes in the ratio of SFA to MUFA
containing PE P species. However this treatment did significantly lower the SFA to PUFA plas-
malogen ratio (Fig 4B). On the other hand loading with oxLDL significantly reduced both, the
SFA to MUFA plasmalogen ratio and to a lesser extent also the SFA to PUFA plasmalogen ratio.
A lower proportion of plasmalogens containing saturated acyl-residues typically corresponds to
more fluid cell membranes. Deloading with HDL3 did not have a significant effect on either of
these ratios.
The PC to free cholesterol (FC) ratio (Fig 4C) was significantly decreased by treatment with
both lipoproteins from 1.7 in macrophages to values around 0.7 to 0.8 in lipid loaded cells.
Higher PC to FC ratios in control cells point towards more fluid membranes, while lower
ratios in lipoprotein treated cells suggest a more rigid membrane structure. Deloading with
HDL3 also did not have a significant impact on the PC to FC ratio.
Fig 3. Individual PE plasmalogen species. (A) Relative changes (log2 fold change) of individual plasmalogen species on day
five after 24h loading with either eLDL (black bars) or oxLDL (grey bars) in comparison to controls. (B) Relative changes in
cells deloaded with HDL3 for 24h following eLDL or oxLDL treatment in comparison to loaded controls. (C) Percentage of
arachidonic acid (20:4) containing PE Ps relative to total PE Ps 24h after lipoprotein loading. (D) Percentage of arachidonic
acid containing plasmalogens 48h after lipoprotein loading and following 24h HDL3-mediated deloading in respective cells.
n = 9 for all experiments except n = 8 for 6d MCSF control data. C and D: mean percentages +/- SD; ( p<0.05,  p<0.01).
https://doi.org/10.1371/journal.pone.0205706.g003
Fig 4. Estimation of membrane fluidity by calculation of lipid ratios on day six. (A) The ratios of saturated to mono-unsaturated PE P species and (B) of saturated
to poly-unsaturated PE Ps were calculated as markers for membrane fluidity in control and treated cells on day six. Additionally the mean PC to FC ratio was
determined (C). Means +/- SD, n = 9 for control and deload measurements and n = 8 for loaded cells; (a: p<0.001 against control and eLDL loaded cells, b: p<0.001
against control cells, c: p<0.05 against controls, d: p<0.01 against controls).
https://doi.org/10.1371/journal.pone.0205706.g004
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Transcriptomics
The lipid composition of a cell directly influences a variety of parameters such as membrane
fluidity, channel function and clustering of membrane proteins. Still an even wider range of
effects can be mediated directly or indirectly by modulation of gene expression. To gain insight
into the transcriptomic regulation, we performed Agilent microarrays on control, lipoprotein
treated and HDL3 deloaded cells. Hypergeometrical scores for the regulation of all detectable
transcripts can be found in a supplementary table (S1 File).
Fig 5 displays a heatmap of gene wise calculated hypergeometrical scores, sorted in
descending order in eLDL loaded cells (A) and in oxLDL loaded cells (B). eLDL and oxLDL
induced unique patterns of transcriptomic regulation that were considerably dissimilar from
each other. As a common feature, both lipoproteins showed downregulation of the same tran-
scripts at the bottom of Fig 5A and 5B. Among others especially transcripts for lipid metabo-
lism related proteins such as the LDL receptor (LDLR), insulin induced gene 1 (INSIG1), fatty
acid synthase (FASN), and mevalonate diphosphate decarboxylase (MVD), but also key tran-
scription factors such as Sterol regulatory element-binding transcription factor 1 (SREBF1)
Fig 5. Heatmap of hypergeometrical scores for transcripts quantified in Agilent microarrays. Red signifies positive and blue negative values, indicating up- and
down regulation respectively. (A) sorted by “eLDL load” hypergeometrical score, (B) sorted by “oxLDL load” hypergeometrical score. n = 9 microarray profiles from
independent donors.
https://doi.org/10.1371/journal.pone.0205706.g005
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and lipid transporters such as ATP Binding Cassette Subfamily A Member 6 (ABCA6) can be
found in this group.
Another feature visible in Fig 5A is that deloading of eLDL treated cells with HDL3 was
barely able to reverse the effects on transcript levels induced by lipid loading. In contrast,
deloading of cells loaded with oxLDL (Fig 5B) induced a marked antagonistic effect on previ-
ously regulated transcripts. Lipid metabolism related transcripts and chemokine receptors
such as GPCR coupled receptors that had been suppressed by loading with oxLDL are strongly
upregulated after deloading with oxLDL. On the other hand previously upregulated transcripts
related to metallothioneins and amino acid metabolism become strongly downregulated.
To further characterize the transcriptomic effects induced by lipid loading and deloading
we used the PANTHER Overrepresentation Test (release 20170413) and annotated the results
with Reactome pathways. A cut-off value of>6 was chosen for the hypergeometrical score to
classify significantly up- and downregulated transcripts. Resulting, significantly affected path-
ways are depicted with the respective lowest levels of hierarchy in Fig 6 and additionally listed
with full details in the supplement (S2 File). As indicated by the strong enrichment, loading
with eLDL suppressed the pathways for cholesterol biosynthesis both via lathosterol and via
desmosterol. The pattern of gene regulation was consistent with a sterol regulatory element
binding protein (SREBP) mediated mechanism, since known SREBP2 target genes were signif-
icantly overrepresented. The LDL-receptor, responsible for the uptake of exogenous choles-
terol, was downregulated with the highest hypergeometrical score of all genes investigated.
Additionally key enzymes in fatty acid and cholesterol metabolism such as stearoyl-CoA desa-
turase-1 (SCD) and squalene epoxidase (SQLE) were strongly suppressed. Furthermore
expression levels of alpha- and beta-tubulins were increased after lipoprotein loading. Because
tubulins play an important role in a variety of pathways such as transport of connexin hemi-
channels, multiple pathways containing tubulins were also identified by the algorithm. Deload-
ing of eLDL treated cells with HDL3 led to a counter-regulatory activation of cholesterol
biosynthesis. Furthermore transcripts involved in glutathione metabolism via glutathione S-
transferases were upregulated. Following loading with eLDL and also after loading with
oxLDL we observed a downregulation of C-C and C-X-C chemokine receptors and ligands.
Similar to treatment with eLDL, loading with oxidized LDL impeded endogenous lipid syn-
thesis and external lipid uptake in a SREBP dependent manner. Furthermore lipid catabolism
was induced through short-chain acyl-CoA dehydrogenase (ACADS), acyl-CoA synthetase
family member 2 (ACSF2) as well as the lipid droplet forming protein perilipin 2. Interestingly
transcripts for HLA class II molecules and genes involved in interferon-γ signaling were also
diminished. Potentially in response to copper oxidized LDL, metallothioneins showed
increases in transcript levels.
Deloading of oxLDL treated macrophages led to the upregulation of transcripts responsible
for cholesterol biosynthesis via lathosterol as well as desmosterol. SREBP2 targets were found
statistically enriched. Likewise we observed potential Rho GTPase mediated changes in cyto-
skeleton associated transcripts. A wide range of tubulin and actin mRNAs were upregulated.
Upregulated genes were also found in pathways involved in cytokine signaling and the innate
immune system. Especially C-C motif chemokines were overrepresented in the microarray
dataset. A downregulation was induced by HDL3 in the categories metallothionin binding pro-
teins, cytosolic tRNA aminoacylation, kinesins, and transcripts related to mitosis and meiosis.
M1/M2 phenotype flow cytometry
Depending on the microenvironment macrophages are able to develop either a classically acti-
vated M1 phenotype or an alternatively activated M2 phenotype. While M1 macrophages
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stimulate inflammation, M2 macrophages curb inflammation and play an important role in
tissue repair processes [6, 30]. Therefore we hypothesized that exposure to eLDL or oxLDL
might modulate macrophage polarization. CD163 (scavenger receptor cysteine-rich type 1
protein M130; hemoglobin/haptoglobin receptor) and CD206 (C-type 1 lectin receptor; man-
nose receptor) were used as M2 markers while CCR7 (C-C chemokine receptor type 7,
Fig 6. Graphical representation of overrepresented Reactome pathways. For improved clarity only the lowest level of hierarchy in each affected pathway is
depicted. Pathways were sorted and color coded according to Bonferroni corrected p-values, dot sizes correspond to Reactome category sizes. n = 9 analyses from
independent donors.
https://doi.org/10.1371/journal.pone.0205706.g006
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CD197) and CD11c served as M1 markers. As shown in Fig 7 treatment with eLDL did only
reduce CD11c surface expression significantly. All three other markers remained unaffected,
indicating only a minor influence on the M1/M2 phenotype. On the other hand oxidized LDL
led to lower expression of CD206 as well as of CD163 and CD11c, while leading to higher levels
of CCR7. Therefore three of the four marker proteins are consistent with a shift towards an
M1 phenotype after treatment with oxLDL.
Discussion
Clearance of lipids and lipoproteins by macrophages is known to play a central role in the biol-
ogy of cardiovascular disease. Enzymatic and oxidative modifications are the most common
ways of lipoprotein modification and in vivo a combination of both contributes to the forma-
tion of atherosclerotic plaques [31]. For the current study we used a model system with eLDL
and oxLDL to study their effects on human monocyte-derived macrophages individually.
Fig 7. Flow cytometric analysis of M1/M2 surface markers in lipoprotein-treated macrophages. CD163 (scavenger receptor cysteine-rich type 1 protein M130;
hemoglobin/haptoglobin receptor) and CD206 (C-type 1 lectin receptor; mannose receptor) were used as M2 markers while CCR7 (CD197) and CD11c served as
M1 markers. Loading with eLDL only induced a statistically significant decrease in CD11c surface expression. On the other hand loading with oxLDL led to
significant decreases in CD163 and CD11c, as well as to increases in CCR7 and a not statistically significant decrease in CD206. n = 6, means +/- SD; (p<0.05, 
p<0.01,  p<0.001).
https://doi.org/10.1371/journal.pone.0205706.g007
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When macrophages are exposed to lipids, there are multiple ways how this can influence
the cell. First of all lipoprotein derived lipids can be directly incorporated into cell membranes
and change their structure and physiological properties. The lipid composition of eLDL and
oxLDL has been reported in a previous publication by our group [29]. Both lipoproteins are
very rich in cholesteryl esters, as well as in free cholesterol. To a lower degree they contain PC
and LPC. PE and phosphatidylinositol (PI) species are only present in relatively small
amounts. In direct comparison eLDL encompasses a higher amount of free cholesterol than
oxLDL, while oxLDL contains relatively higher quantities of PC and LPC species.
In our experiments in vitro loading of macrophages induced specific alterations in cellular
phospholipid levels that did transiently and partially correlate with the lipoprotein lipid pat-
tern. On day five total PE and PE P levels remained stable, while total PC, PC P and especially
LPC levels were increased significantly. This indicates an instant lipid uptake from the lipopro-
tein. On day six most of the changes from day five were not detectable any more. Only the ele-
vation of LPC after oxLDL loading remained statistically significant. Therefore cellular lipid
metabolism seems to be able to swiftly cope with the exogenous lipid load and preserve the
global lipid composition of the cell. Nevertheless chronic exposition of macrophages to modi-
fied lipoproteins in an atherosclerotic lesion could lead to chronically elevated levels of LPC
and other phospholipids in these cells. This corresponds well with observations describing
raised levels of oleic acid (18:1 in sn-2) containing LPC species as novel biomarkers for the ath-
erogenic state [32].
Furthermore in fibroblasts free cholesterol is known to be able to upregulate PC biosynthe-
sis [33]. In our lipoprotein treated macrophages we potentially observed a similar effect.
Despite a lower content of PC in eLDL particles, total PC levels increased stronger after load-
ing with eLDL compared to loading with oxLDL. Moreover PE synthesis can be inhibited in
fibroblasts by incubation with free cholesterol. In our experiments we only observed visibly
but not statistically significantly lower PE levels after lipoprotein loading. We did however
detect a shift toward polyunsaturated PE plasmalogen species through a reduction of saturated
and monounsaturated species.
Surprisingly HDL3 mediated deloading only had a very limited influence on the cellular
lipidomic profile. Day six macrophages were able to normalize levels of most lipid species
already without lipoprotein mediated deloading. Only PC P-34:2 was found significantly lower
after deloading with HDL3.
The fluidity of the membrane bilayer represents a crucial factor influencing membrane
dependent functions such as migration, mitosis, phagocytosis and vesicular trafficking.
Among others the PC to FC ratio is generally regarded as a marker of membrane fluidity. In
our experiments as well as in atherosclerotic plaques, cells are exposed to abundant amounts
of free cholesterol. Correspondingly we detected a lower total PC to FC ratio after lipoprotein
treatment. The PC to FC ratio was decreased by treatment with both lipoprotein fractions
from 1.7 in control macrophages to values around 0.6 in lipid loaded cells. A previous study
on primary human blood cells yielded values of 1.9 in monocytes, 1.3 in lymphocytes, 1.1 in
granulocytes, 0.8 in platelets and 0.3 in red blood cells [16]. Higher ratios indicate more fluid
membranes that enable cells to migrate more easily and that facilitate phagocytic activity and
vesicular processing [34, 35]. Exposure of macrophages to high amounts of free cholesterol
therefore seems to lead to less fluid membranes that are more susceptible to mechanical dam-
age [36, 37]. Interestingly the PE P saturation pattern did show opposing effects that could be
able to counteract the increased membrane rigidity induced by the high FC load. Plasmalogens
are regulators of membrane fluidity and affect membrane dynamics through their ether bond
[38]. While saturated and monounsaturated species in sn-2 position lead to more stable struc-
tures, plasmalogens with higher degrees of unsaturation result in more fluid membranes.
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Indeed the relative amount of saturated PE P species decreased after lipid loading with either
lipoprotein in comparison to mono-unsaturated and poly-unsaturated PE P species. These
findings are also consistent with a previous NMR study that showed a significant shift in the
degree of saturation towards mainly polyunsaturated fatty acid chains in the mobile lipid pool
of eLDL loaded macrophages [39]. Interestingly deloading with HDL3 did not have an effect
on the analyzed membrane fluidity marker ratios.
Lipid raft microdomains are closely connected to membrane fluidity. They are cholesterol-
rich and harbor a wide range of signaling molecules [40, 41]. They therefore play crucial roles
in cell-to-cell signaling, survival, immune-receptor signaling as well as in endocytosis [42].
The proteins within lipid rafts are sensitive to changes in the lipid composition and rising or
falling levels of lipids can activate associated proteins such as death receptors and influence
apoptosis [43]. Plasmalogens represent a major constituent of lipid raft microdomains and are
able to enhance raft stability [44]. The observed decrease in saturated and monounsaturated
PE Ps in eLDL treated cells might therefore lead to more fluid and less stable lipid raft micro-
domains and subsequently facilitate signal transduction processes. Interestingly plasmalogen
deficient mice exhibit disrupted lipid raft formation [41].
To examine the effects of lipid loading on gene expression we performed Agilent microar-
ray analysis. Treatment with eLDL as well as with oxLDL led to a strong downregulation of
endogenous cholesterol biosynthesis and external uptake. As indicated by Panther pathway
overrepresentation analysis this is likely mediated through sterol regulatory element binding
proteins (SREBPs). SREBPs represent a family of transcription-factors that play key roles in
the regulation of sterol metabolism. Especially SREBP-2 is responsible for the feedback regula-
tion of de-novo cholesterol biosynthesis and known to control key transcripts [45]. Also choles-
terol overloading is known to lead to the activation of the liver X receptor (LXR) [46]. In
addition levels of PUFA containing PE Ps play a direct role in the regulation of cellular choles-
terol via a concentration-dependent increase in sterol-O-acyltransferase-1 (SOAT1) [47].
These effects are generally more pronounced in eLDL loaded cells. While cholesterol taken up
from oxLDL is trapped in endolysosomes and leads to phospholipidosis, free cholesterol taken
up from eLDL accumulates in the ER and leads to rapid lipid droplet formation [10]. Interest-
ingly deloading with HDL3 was able to partially rescue the transcriptomic expression profile
only in oxLDL treated cells. The effects in eLDL loaded cells were substantially smaller. There-
fore high concentrations of HDL cholesterol in vivo could be able to transcriptomically attenu-
ate the pro-inflammatory effects of oxidized lipoprotein components on macrophages.
To investigate if lipoprotein loading is able to influence the phenotype of macrophages we
used a flow cytometric approach. Using two typical M1 and two typical M2 surface markers
we found a shift towards a more M1-like phenotype after oxLDL treatment. Three of the four
markers were changed towards the M1 phenotype. Functionally this points towards a higher
inflammatory potential. Further evidence of an increased inflammatory potential could be
observed in the lipidomic analysis of arachidonic acid containing PE plasmalogens. These
abundant species serve as a reservoir for the synthesis of prostanoids and other inflammatory
mediator molecules. Potentially due to the consumption in downstream synthesis processes,
oxLDL loaded macrophages showed a significantly lower content of PE P with arachidonic
acid in sn-2 than control or eLDL loaded cells.
These findings are also interesting in light of the transcriptomic effect we found on tran-
scripts associated with the Reactome category microtubules. Microtubules are for example
used for the secretion of MMP-9 in macrophages [48]. Also assembly of the NLRP3 inflamma-
some is mediated by alpha tubulin [49]. A Rho-GTPase mediated modulation of the microtu-
bule system could therefore also alter the inflammatory potential of lipid exposed
macrophages. Intracellular accumulation of fatty acids, especially stearic acid has been
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previously associated with development of an pro-inflammatory M1 phenotype in macro-
phages [50].
Unfortunately only limited data are available about the associations of plasmalogens with
human diseases. However there is increasing evidence that plasmalogens are significantly
involved in chronic metabolic disorders. In general lower plasmalogen levels have been linked
to disease development and progression. For example decreased plasmalogen levels in serum
are associated with hypertension, obesity, coronary artery disease, and myocardial infarction
[18, 51–54]. This also seems to be a metabolic rather than a genetic effect since obese twins
exhibit lower serum plasmalogens than their non-obese healthy siblings [51]. Conversely aero-
bic training and a healthy dietary intervention lead to increased serum plasmalogen levels [55,
56]. Likewise plasmalogen supplementation was able to attenuate atherosclerosis in a mouse
model [57].
In human macrophages we found no significant changes of total PE P levels after lipopro-
tein loading. However there was a clear saturation dependent modulation of the plasmalogen
species pattern. Especially eLDL induced isolated reductions in saturated, mono- and di-unsat-
urated species. Furthermore loading with eLDL did significantly decrease PC P-30:0 and sig-
nificantly increase PC P-34:2 and PC P-36:4. In contrast loading with oxLDL did significantly
increase total PC P levels. Therefore the observed short-term effects in macrophages seem to
diverge from long-term observations in plasma. Beyond that our data also show diminished
levels of linolenic acid (18:3) containing plasmalogens after eLDL loading. The n-3 fatty acid
alpha-linolenic acid (18:3 n-3) possesses a range of beneficial effects in cardiovascular disease
[58]. In our mass spectrometric setup it is not possible to differentiate between alpha- and
gamma-linolenic acid as plasmalogen residues. Therefore a loss of the beneficial effects of
alpha linolenic acid (18:3 n-3) is speculative at the moment.
Decreased serum ether lipids and increased LPC species represent some of the earliest
markers for the development of type 1 diabetes (T1D) in children. These changes are present
even before autoantibodies are detectable, suggesting metabolic dysregulation even preceding
the immune response [59]. Still if the altered lipid pattern is causative for the development of
the disease or if dyslipidemia is a secondary metabolic effect remains yet unclear. Anti-oxida-
tive properties might form the link between low plasmalogen levels and the development of
T1D. Beta cells only possess a very low anti-oxidative capacity [60]. Therefore lower total plas-
malogen levels might render beta-cells more susceptible to metabolic stress and damage.
Furthermore PE, PI and phosphatidylglycerol (PG), but not PC species show positive asso-
ciations with type 2 diabetes and prediabetes. Here it has also been speculated that increased
levels of PE P as a reservoir for arachidonic acid could contribute to increased synthesis of
proinflammatory eicosanoids [61]. This is consistent with our findings of significantly lower
relative amounts of AA containing PE Ps after oxLDL loading, as well as with our flow cyto-
metric findings. Furthermore eLDL loading led to lower cellular levels of 20:3 DGLA contain-
ing species that could serve as precursors for prostaglandin E1 (PGE1) and prostaglandin F1
(PGF1) production.
Summary and conclusion
Treatment of human macrophages with eLDL and oxLDL induced transient changes in cellu-
lar phosopholipid levels. Some of these effects, particularly in PC and PE plasmalogens were
saturation dependent and could not be fully explained by direct lipid uptake. Intracellularly
they were accompanied by the downregulation of endogenous cholesterol synthesis and exoge-
nous uptake, as well as potentially an induction of PC synthesis and an inhibition of PE synthe-
sis. Very likely these adaptions serve the purpose of keeping the lipidomic composition of the
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cell and its organelles as stable as possible, as we examined for membrane fluidity and lipid raft
function. Functionally the macrophages exhibited a shift towards a more M1 like marker pat-
tern after lipid loading. This finding is consistent with lipidomics showing the consumption of
arachidonic acid containing PE plasmalogens and most likely indicates the induction of a pro-
inflammatory phenotype. Our data therefore provide some novel information for the under-
standing of lipid biomarkers that have been described before in serum.
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